Semi-mechanistic pharmacokinetic model to guide the dose selection of nimotuzumab in patients with autosomal dominant polycystic kidney disease

  1. de Castro-Suárez, N.
  2. Trame, M.N.
  3. Ramos-Suzarte, M.
  4. Dávalos, J.M.
  5. Bacallao-Mendez, R.A.
  6. Maceo-Sinabele, A.R.
  7. Mangas-Sanjuán, V.
  8. Reynaldo-Fernández, G.
  9. Rodríguez-Vera, L.
Journal:
Pharmaceutics

ISSN: 1999-4923

Year of publication: 2020

Volume: 12

Issue: 12

Pages: 1-14

Type: Article

DOI: 10.3390/PHARMACEUTICS12121147 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals